Evidence map›Paper›PMID 23170010›Full record

ArticleCirculation. Heart failure2013

Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure.

Peter A Hecker, Vincenzo Lionetti, Rogerio F Ribeiro, Sharad Rastogi, Bethany H Brown, Kelly A O'Connell, James W Cox, Kadambari C Shekar, Dionna M Gamble, Hani N Sabbah and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Heart failure, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
8.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Improving metabolic support during normothermicFrontiers in cardiovascular medicine · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Peter A HeckerDivision of Cardiology and Department of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Vincenzo Lionetti
Rogerio F Ribeiro
Sharad Rastogi
Bethany H Brown
Kelly A O'Connell
James W Cox
Kadambari C Shekar
Dionna M Gamble
Hani N Sabbah
Jane A Leopold
Sachin A Gupte
Fabio A Recchia
William C Stanley
Brigham and Women's Hospital · USUniversity of South Alabama · USHenry Ford Hospital · USHarvard University · US

Funding

Substrate Selection and Oxidative Stress in Heart FailureP01HL074237 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI STANLEY, WILLIAM C · 2003 to 2013
$19.9M
Training Grant in Cardiac and Vascular Cell BiologyT32HL072751 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI FISHER, STEVEN A. · 2003 to 2013
$3.1M
Intergrated Endothelial Phenotyping to Redefine Pulmonary HypertensionU01HL125215 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEOPOLD, JANE A, WAXMAN, AARON B · 2014 to 2018
$1.7M
Aldosterone, Autophagy, and Arterial StiffnessR01HL105301 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEOPOLD, JANE A · 2010 to 2013
$1.6M
NHLBI NIH HHS P01 HL074237NHLBI NIH HHS R01 HL105301NHLBI NIH HHS T32 HL072751NHLBI NIH HHS U01 HL125215
6 · The paper itself

Abstract

backgroundGlucose 6-phosphate dehydrogenase (G6PD) is the most common deficient enzyme in the world. In failing hearts, G6PD is upregulated and generates reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is used by the glutathione pathway to remove reactive oxygen species but also as a substrate by reactive oxygen species-generating enzymes. Therefore, G6PD deficiency might prevent heart failure by decreasing NADPH and reactive oxygen species production. METHODS AND

resultsThis hypothesis was evaluated in a mouse model of human G6PD deficiency (G6PDX mice, ≈40% normal activity). Myocardial infarction with 3 months follow-up resulted in left ventricular dilation and dysfunction in both wild-type and G6PDX mice but significantly greater end diastolic volume and wall thinning in G6PDX mice. Similarly, pressure overload induced by transverse aortic constriction (TAC) for 6 weeks caused greater left ventricular dilation in G6PDX mice than wild-type mice. We further stressed transverse aortic constriction mice by feeding a high fructose diet to increase flux through G6PD and reactive oxygen species production and again observed worse left ventricular remodeling and a lower ejection fraction in G6PDX than wild-type mice. Tissue content of lipid peroxidation products was increased in G6PDX mice in response to infarction and aconitase activity was decreased with transverse aortic constriction, suggesting that G6PD deficiency increases myocardial oxidative stress and subsequent damage.

conclusionsContrary to our hypothesis, G6PD deficiency increased redox stress in response to infarction or pressure overload. However, we found only a modest acceleration of left ventricular remodeling, suggesting that, in individuals with G6PD deficiency and concurrent hypertension or myocardial infarction, the risk for developing heart failure is higher but limited by compensatory mechanisms.

Indexed as

Ventricular RemodelingAnimalsDisease Models, AnimalDisease ProgressionGlucosephosphate DehydrogenaseGlucosephosphate Dehydrogenase DeficiencyHeart FailureLipid PeroxidationMaleMiceMice, Inbred C3HMyocardiumOxidation-ReductionReactive Oxygen SpeciesGlucosephosphate DehydrogenaseReactive Oxygen Species

Identifiers

PMID23170010
PMCPMC5469404
OpenAlexW2034379027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.